Clinical Report: Nutritional Strategies for Managing Dry Eye Disease Symptoms

Overview

Dry eye disease (DED) affects approximately 38 million U.S. adults and significantly impairs quality of life. Emerging evidence highlights the role of nutrition, particularly deficiencies and supplementation of specific vitamins and fatty acids, in modulating ocular surface inflammation and symptom severity.

Background

DED is a multifactorial, chronic, progressive inflammatory condition primarily managed with topical therapies. However, the proinflammatory Standard American Diet contributes to meibomian gland dysfunction and exacerbates DED. Nutritional factors such as vitamins A, C, D, B12, antioxidants like lutein and zeaxanthin, and fatty acids including omega-3 and gamma-linolenic acid play critical roles in ocular surface health and inflammation modulation. Integrating targeted nutritional supplementation alongside conventional treatments may improve patient outcomes.

Data Highlights

Approximately 38 million U.S. adults experience dry eye symptoms. Vitamin C is present in ocular tissues at concentrations 20 to 30 times higher than in serum. Research demonstrates significant associations between low serum vitamin D levels and DED occurrence. Supplementation with omega-3 fatty acids has been shown to reduce inflammation, improve tear film quality, and promote corneal healing.

Key Findings

• The Standard American Diet is a major proinflammatory driver of meibomian gland dysfunction and DED.
• Vitamin A deficiency leads to goblet cell loss, mucin deficiency, and corneal epithelial damage; supplementation improves ocular surface health.
• Vitamin C acts as an antioxidant and anti-inflammatory agent, aiding corneal wound repair and reducing inflammation.
• Vitamin D modulates immune responses, suppresses corneal inflammation, and low serum levels correlate with increased DED risk.
• Lutein and zeaxanthin reduce oxidative stress and inflammation by modulating gene expression related to cytokine production.
• Omega-3 fatty acids decrease ocular inflammation, enhance tear film quality, and support corneal nerve regeneration.
• Gamma-linolenic acid (GLA), an omega-6 fatty acid, has anti-inflammatory effects but requires concurrent omega-3 intake to prevent proinflammatory conversion.
• Vitamin B12 supplementation improves dry eye symptoms, particularly in patients with neuropathic ocular pain.

Clinical Implications

Clinicians should consider evaluating patients' nutritional status as part of comprehensive DED management. Supplementation with vitamins A, C, D, B12, antioxidants, and omega-3 fatty acids can complement topical therapies by targeting underlying inflammation and promoting ocular surface repair. Coordinated use of GLA with omega-3s is recommended to maximize anti-inflammatory benefits.

Conclusion

Nutritional interventions represent a valuable adjunct to conventional topical treatments for dry eye disease. Addressing dietary factors and targeted supplementation can disrupt ocular surface inflammation and improve patient symptoms and quality of life.

References

1. Poteet JA, 2024 -- Getting to the Root of Dry Eye Symptom Management With Nutrition